Sale!

STIM1 Gene Myopathy Tubular Aggregate Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

The “STIM1 Gene Myopathy Tubular Aggregate Type 1 Genetic Test” is a specialized diagnostic examination conducted to identify mutations in the STIM1 gene, which are associated with a rare condition known as Tubular Aggregate Myopathy Type 1. This condition is characterized by muscle weakness and fatigue, with tubular aggregates found in muscle cells upon biopsy, which are indicative of abnormal calcium regulation. The STIM1 gene plays a crucial role in calcium signaling within cells, and mutations can disrupt this process, leading to the symptoms observed in affected individuals.

The test is performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. With a cost of 3200 AED, the test offers a comprehensive analysis of the STIM1 gene to confirm a diagnosis, enabling targeted management and treatment strategies for patients. It is particularly valuable for individuals showing symptoms of muscle weakness or those with a family history of Tubular Aggregate Myopathy, providing crucial insights into their condition and guiding healthcare decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

STIM1 Gene Myopathy Tubular Aggregate Type 1 Genetic Test

Cost: 3200.0 AED

Test Details:

STIM1 gene myopathy, tubular aggregate, type 1 is a rare genetic disorder characterized by muscle weakness and wasting. It is caused by mutations in the STIM1 gene, which provides instructions for producing a protein involved in calcium regulation in muscle cells.

Components:

  • Price: 3200.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for STIM1 Gene Myopathy, tubular aggregate, type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with STIM1 Gene Myopathy, tubular aggregate, type 1.

Test Process:

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. It allows for the identification of specific genetic mutations or variations associated with a particular disorder, such as STIM1 gene myopathy. NGS genetic testing for STIM1 gene myopathy, tubular aggregate, type 1 involves obtaining a DNA sample, usually through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the STIM1 gene.

Benefits and Implications:

The results of the NGS genetic test can help confirm a diagnosis of STIM1 gene myopathy and guide treatment decisions. It can also provide valuable information for genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing is appropriate for individuals suspected of having STIM1 gene myopathy, tubular aggregate, type 1. They can provide further information on the test, its benefits, limitations, and potential implications.

Test Name STIM1 Gene Myopathy tubular aggregate type 1 Genetic Test
Components
Price 3200.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for STIM1 Gene Myopathy, tubular aggregate, type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with STIM1 Gene Myopathy, tubular aggregate, type 1
Test Details

STIM1 gene myopathy, tubular aggregate, type 1 is a rare genetic disorder characterized by muscle weakness and wasting. It is caused by mutations in the STIM1 gene, which provides instructions for producing a protein involved in calcium regulation in muscle cells.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. It allows for the identification of specific genetic mutations or variations associated with a particular disorder, such as STIM1 gene myopathy.

NGS genetic testing for STIM1 gene myopathy, tubular aggregate, type 1 involves obtaining a DNA sample, usually through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the STIM1 gene.

The results of the NGS genetic test can help confirm a diagnosis of STIM1 gene myopathy and guide treatment decisions. It can also provide valuable information for genetic counseling and family planning.

It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing is appropriate for individuals suspected of having STIM1 gene myopathy, tubular aggregate, type 1. They can provide further information on the test, its benefits, limitations, and potential implications.